Related Experiment Video
Updated: Sep 3, 2026

Ole Isacson: Development of New Therapies for Parkinson's Disease
Published on: April 29, 2007
How common are complications of Parkinson's disease?
Anette Schrag1, Yoav Ben-Shlomo, Niall Quinn
1Department of Clinical Neurology, Institute of Neurology, Queen Square, London WC1N3BG, UK. a.schrag@ion.ucl.ac.uk
Background:
Parkinson's disease (PD) can be associated with a wide range of complications of advancing disease and treatment. However, it is unclear how often these occur in the overall population of patients with PD.
Objective:
To assess the prevalence of disease and treatment complications and their clinical correlates in a community-based sample of 124 patients with PD.
Results:
Average current age was 72 (SD 10.9) and mean disease duration 6 (SD 4.3) years. Falls with postural instability and other axial features were among the most common complications of advancing disease in this population (64 %). Motor fluctuations and dyskinesias affected approximately 30 and 20 % of the overall sample respectively, and changes in mental state such as dementia, depression and hallucinations each affected approximately one fifth of patients. Symptoms of autonomic nervous system dysfunction occurred in the great majority of patients, but were not associated with greater disease severity, disease duration or overall disability.
Conclusion:
In contrast to clinic-based samples, the most frequently occurring complications of PD in this community-based sample were axial features such as postural instability with falls. These factors should be more taken into account in the allocation of health care resources and the treatment of symptoms of patients with PD in the community.
More Related Videos
07:26Characterizing the Relationship Between Eye Movement Parameters and Cognitive Functions in Non-demented Parkinson's Disease Patients with Eye Tracking
Published on: September 26, 2019
05:51Induction and Assessment of Levodopa-induced Dyskinesias in a Rat Model of Parkinson's Disease
Published on: October 14, 2021
Related Concept Videos
Parkinson's Disease: Overview
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications
Complications of Diabetes Mellitus
Parkinson Disease l: Introduction
Parkinson Disease ll: Pathophysiology